• Explore /
  • Poster
  • / PD-1 antibody combined with paclitaxel (albumin bound) and gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.

PD-1 antibody combined with paclitaxel (albumin bound) and gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.

Abstract Video & Slides Poster

Authors

null

Jiujie Cui

Department of Medical Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, Shanghai, China

Jiujie Cui , Jiayu Yao , Yu Wang , Yiyi Liang , Yongchao Wang , Feng Jiao , Xiao Zhang , Ting Han , Tiebo Mao , Qing Xia , Xiuying Xiao , Haiyan Yang , Li-Wei Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT04181645

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS4665)

DOI

10.1200/JCO.2020.38.15_suppl.TPS4665

Abstract #

TPS4665

Poster Bd #

273

Abstract Disclosures

Similar Posters

First Author: Gang Jin

First Author: John Ebben

First Author: Jianqing Zhu

First Author: Li-Yuan Bai